Atomi Financial Group Inc. boosted its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 9.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,638 shares of the financial services provider’s stock after buying an additional 548 shares during the quarter. Atomi Financial Group Inc.’s holdings in MetLife were worth $544,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of MET. MeadowBrook Investment Advisors LLC increased its position in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after buying an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. increased its position in MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after buying an additional 186 shares during the last quarter. Wolff Wiese Magana LLC increased its position in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after buying an additional 277 shares during the last quarter. Peterson Financial Group Inc. acquired a new position in MetLife during the third quarter worth $30,000. Finally, Retirement Wealth Solutions LLC acquired a new position in MetLife during the fourth quarter worth $32,000. 94.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
MET has been the topic of several research analyst reports. Jefferies Financial Group raised their price target on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Wells Fargo & Company lowered their price target on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 14th. Piper Sandler raised their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. BMO Capital Markets initiated coverage on MetLife in a research report on Thursday. They issued a “market perform” rating and a $97.00 price target on the stock. Finally, Barclays raised their price target on MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, January 6th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $90.46.
MetLife Stock Up 1.2 %
Shares of MET opened at $86.82 on Friday. The stock has a market cap of $60.11 billion, a price-to-earnings ratio of 17.50, a P/E/G ratio of 0.66 and a beta of 1.07. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a 12 month low of $64.61 and a 12 month high of $89.05. The company has a 50-day moving average price of $83.68 and a two-hundred day moving average price of $79.82.
MetLife Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio is 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- High Flyers: 3 Natural Gas Stocks for March 2022
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What is the Australian Securities Exchange (ASX)
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.